全文获取类型
收费全文 | 1314篇 |
免费 | 79篇 |
国内免费 | 59篇 |
专业分类
儿科学 | 46篇 |
妇产科学 | 11篇 |
基础医学 | 153篇 |
口腔科学 | 21篇 |
临床医学 | 167篇 |
内科学 | 288篇 |
皮肤病学 | 20篇 |
神经病学 | 102篇 |
特种医学 | 237篇 |
外科学 | 132篇 |
综合类 | 30篇 |
一般理论 | 2篇 |
预防医学 | 71篇 |
眼科学 | 12篇 |
药学 | 88篇 |
中国医学 | 2篇 |
肿瘤学 | 70篇 |
出版年
2023年 | 4篇 |
2022年 | 5篇 |
2021年 | 17篇 |
2020年 | 11篇 |
2019年 | 16篇 |
2018年 | 32篇 |
2017年 | 14篇 |
2016年 | 16篇 |
2015年 | 26篇 |
2014年 | 40篇 |
2013年 | 46篇 |
2012年 | 38篇 |
2011年 | 41篇 |
2010年 | 43篇 |
2009年 | 34篇 |
2008年 | 30篇 |
2007年 | 70篇 |
2006年 | 25篇 |
2005年 | 42篇 |
2004年 | 37篇 |
2003年 | 39篇 |
2002年 | 30篇 |
2001年 | 23篇 |
2000年 | 19篇 |
1999年 | 29篇 |
1998年 | 56篇 |
1997年 | 41篇 |
1996年 | 64篇 |
1995年 | 51篇 |
1994年 | 43篇 |
1993年 | 56篇 |
1992年 | 21篇 |
1991年 | 21篇 |
1990年 | 38篇 |
1989年 | 32篇 |
1988年 | 41篇 |
1987年 | 44篇 |
1986年 | 32篇 |
1985年 | 34篇 |
1984年 | 16篇 |
1983年 | 12篇 |
1982年 | 15篇 |
1981年 | 25篇 |
1980年 | 22篇 |
1979年 | 12篇 |
1978年 | 10篇 |
1977年 | 17篇 |
1976年 | 7篇 |
1975年 | 11篇 |
1963年 | 1篇 |
排序方式: 共有1452条查询结果,搜索用时 531 毫秒
1.
2.
3.
4.
5.
6.
Short-Ti inversion-recovery pulse sequence: analysis and initial experience in cancer imaging 总被引:2,自引:0,他引:2
Inversion recovery (IR), commonly considered a pulse sequence capable of producing T1-weighted images with excellent display of normal anatomy, is versatile: The null point and peak time provide a useful, succinct summary of the properties of IR and its capacity for producing both T1- and T2-weighted images. Shortening of the inversion time (TI) and creation of a short-TI inversion-recovery (STIR) pulse sequence increases sensitivity to malignancy and other abnormalities by making the effects of prolonged T1 and T2 on signal intensity additive and by nulling the signal from fat. The authors examined over 300 patients with various malignancies and compared STIR images with T1- and T2-weighted images obtained at 0.5 T. In 43 cases, signal-difference-to-noise ratios (SD/Ns) were calculated between tumor, fat, and muscle. In general, STIR images demonstrated tumor as a conspicuously high-intensity area in a background of muted, discernible anatomic detail. The good contrast achieved with STIR sequences between tumor and fat (SD/N = 18.1) and tumor and muscle (SD/N = 12.9) consolidated into a single image the information contained separately on T1- and T2-weighted images, which facilitates efficient detection and localization of malignancy. 相似文献
7.
Sixteen cases of histopathologically proved solitary rectal ulcer syndrome were encountered. Fifteen patients underwent barium enema study; in nine cases the findings--including rectal stricture, granularity of the mucosa, and thickened rectal folds-were nonspecific. In six cases the study was normal. All patients had a long history of defecation disorders, and defecography was performed in all. In seven cases, intussusception of the rectal wall was seen; in another case the intussusception was accompanied by a rectocele. One case showed rectal prolapse. In four cases, failed relaxation of the puborectalis occurred and prevented the passage of the bolus; in another case there was abnormal perineal descent. In two patients studies were normal. In patients with defecation disorders, the possibility of this syndrome should be considered. Defecography is the method of choice for establishing the diagnosis. 相似文献
8.
W. Van de Vrie A. M. Jonker R. L. Marquet A. M. M. Eggermont 《Journal of cancer research and clinical oncology》1994,120(9):533-538
the feasibility of using chemosensitizers in the circumvention of P-glycoprotein-mediated multidrug resistance has been shown in many studies. We recently reported on the chemosensitizing effect of cyclosporin A (CsA) on doxorubicin in a rat solid tumour model. Using the same experimental design we investigated the side-effects of the combination treatment. During the 35-day experiment doxorubicin treatment caused dose-dependent weight loss, which was enhanced by combination treatment with CsA. The main doxorubicin-related side-effects were myelosuppression (transient leucopenia and thrombopenia) and nephrotoxicity. Damage to the kidney was severe, leading to a nephrotic syndrome and resulting in ascites, pleural effusion, hypercholesterolaemia and hypertriglyceridaemia. These toxicities were enhanced by the addition of the chemosensitizer CsA. Mild doxorubicin-related cardiomyopathy and minimal hepatotoxicity were seen on histological examination. There were no signs of enhanced toxicity of the combination treatment in tissues with known high expression levels of P-glycoprotein, like the liver, adrenal gland and large intestine. CsA had a low toxicity profile, as it only caused a transient rise in bilirubin. In conclusion, the chemosensitizer CsA enhanced the side-effects of the anticancer drug doxorubiein without altering the toxicity pattern. There was no evidence of a therapeutic gain by adding CsA to doxorubicin, compared to single-agent treatment with doxorubicin in 25%–33% higher doses, because of the enhanced toxicity of the combination treatment.Abbreviations CsA
cyclosporin A
- DOX
doxorubicin
- MDR
multidrug resistance
- PBS
phosphate-buffered saline
This work was supported by the Dr Daniël den Hoed Foundation, Rotterdam, The Netherlands 相似文献
9.
10.
G Steinhoff M Jonker G Gubernatis K Wonigeit W Lauchart A Bornscheuer R Pichlmayr 《Transplantation》1990,49(4):669-674
The effect of single and repeated treatment of liver allograft rejection using an anti-CD3 monoclonal antibody (FN18) was studied in a rhesus monkey model. Eight RhLA-mismatched monkeys received initial postoperative immunosuppression with CsA/prednisolone for 28 days. After cessation, acute rejection occurred in all animals (days 28-50). Control animals (n = 3) receiving no rejection treatment developed a chronic progressive rejection and died at days 112-160. In the animals treated with FN18 (n = 5), the first acute rejection was successfully reversed. T lymphocytes were cleared from the peripheral blood and the graft. Increased class I and class II MHC-antigens on hepatocytes were reduced to normal levels within 5 days of treatment. The second rejection treatment remained ineffective in two animals with antiidiotypic antibodies to FN18 but was successful in two animals with a low antimouse response. These four animals survived 160-509 days. The results have a number of implications regarding the course of untreated rejection in human liver transplant recipients and repetitive rejection treatment with monoclonal antibodies. 相似文献